Filing Flows › Cannapharmarx (CPMD) › Q1 2026 › vs Q4 2025
Cannapharmarx (CPMD) Q1 2026 vs Q4 2025 (quarter over quarter)
Cannapharmarx's revenue rose $489K (+353%) from $139K in Q4 2025 to $627K in Q1 2026.
Cannapharmarx, Q1 2026: revenue $627K (+87% year over year), operating margin -108.7%, net loss $382K, operating cash flow −$244K. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $627K | $139K | $489K | +353% |
| Other income, net | $300K | −$6.7M | $7.0M | — |
| Net loss | $382K | $7.5M | −$7.2M | -95% |
| Costs & expenses | $1.3M | $7.7M | −$6.4M | -83% |
| Operating costs | $1.3M | $1.0M | $278K | +27% |
| Cost of revenue | $1.0M | $660K | $377K | +57% |
| General & admin | $36K | $230K | −$194K | -84% |
| Other operating costs | $237K | $143K | $94K | +66% |
| Operating cash sources | $382K | $7.5M | −$7.2M | -95% |
| Depreciation & amortization | $16K | $0 | $16K | — |
| Working capital & other | $123K | $8.6M | −$8.5M | -99% |
| Cash used in operations | $244K | −$1.1M | $1.3M | — |
| Net loss absorbed | $382K | $7.5M | −$7.2M | -95% |
Questions
How much did Cannapharmarx's revenue grow quarter over quarter in Q1 2026?
Cannapharmarx's revenue rose $489K (+353%) from $139K in Q4 2025 to $627K in Q1 2026.